SOUTH EASTON, MA – January 19, 2023 – Pressure BioSciences, Inc. (OTCQB: PBIO) today announced results from initial consumer focus group testing of a THC Nanoemulsion Oral Spray prepared using PBI’s revolutionary Ultra Shear Technology™ (UltraShear™ or UST™) platform. Preparation of the THC Nanoemulsion Oral Spray was completed and Delivers First Effects and Maximization in Lightning Speed Just Simple, Reliable Dosing Delivers Profoundly Improved Results.
On Thursday, the stock had a great run-up and moved higher by 24.81% on 9X average volume to close at a 5-month high of $1.79. More than 155K shares were traded for the session, compared to its average volume of 17K shares. Moreover, the stock is up 55.65% in 2023.
Pressure BioSciences Inc (OTC:PBIO) is currently one of the more interesting companies due to its work on the development of pressure-based instruments for multiple industries. However, it should also be noted that the company has also come up with its proprietary Ultra Shear Technology platform and this morning it made an announcement with regards to that.
Pressure BioSciences made an announcement about the customer focus group which had tested the HC Nanoemulsion Oral Spray which had been manufactured through the use of the Ultra Shear Technology platform. The product had been prepared with the assistance of the partner companies of Pressure BioSciences based out of California. The announcement this morning was a significant one and marks another significant step in the wider applications to which the Ultra Shear Technology platform could be deployed.
The Director of Sales and Marketing at the company John B Hollister spoke about the latest development as well. He noted that the partner companies in California used Ultra Shear Technology so as to create extreme nanoemulsions of THC and to convert it into an oral spray.
The company had partnered with Crème De Canna to manufacture the product and the president of the latter Jonathan Kolodinski spoke about the same as well. He noted that the product is highly innovative and has already managed to address a significant portion of the market. It now remains to be seen if the latest development brings the Pressure BioSciences stock onto the radars of investors or not.